Advanced Breast Cancer with Genomic Testing
- Inherited genetic mutations account for up to 10% of all breast cancers.
- BRCA 1/2 mutations are the most common and most studied inherited genetic mutation in breast cancer. Approximately 1 in 400 women have a BRCA gene mutation. Women with one of these mutations have up to a 7 in 10 chance of getting breast cancer in their lifetime.
- FGFR stands for Fibroblast Growth Factor Receptor. Around 15% of breast cancers have a FGFR1 gene mutation.
- Many women with breast cancer show no symptoms early in the disease, making routine screening important. Self-breast exams and mammograms are the most common screening measures.
- The most common symptoms in breast cancer are a lump or swelling in the breast or underarm that doesn’t go away, a flat or indented area on the breast, changes in nipple appearance or feeling, and unusual nipple discharge.
- Many breakthroughs in preventative treatments for breast cancer have been made over the past 20+ years including the approval of Raloxifene in 2006!
- There are over 600 breast cancer charities currently active in the United States. An estimated 6 billion dollars is raised each year for breast cancer! People care about this disease and want to help. Reach out to your local organizations!
- The death rate for breast cancer has been continuously dropping by an average of 1.4% per year over the past 10 years!
More Details: Genomic Testing for Breast Cancer
Free Matching to Cancer Clinical Trials
- Your match report contains a detailed list of cervical cancer clinical trials that you may be eligible to enroll in to receive unique and nonconventional treatment. Standard treatment is not the only option.
- A patient advocate will review your report with you to answer any questions or concerns you may have and assist with enrollment if you decide to move forward with a trial.
- There’s no need to travel to a clinical trial site until the enrollment process is complete.
Our number one priority is creating positive outcomes for cancer patients. Let us help you today.
0 Comments